ABOUT KAYENTIS

Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech, and CROs bring simplicity, efficiency, and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble), and Japan (Tokyo), and currently employs 185 staff.

Follow us on LinkedIn to discover new content every week!

kayentis.com

FEATURED ARTICLES

CONTACT INFORMATION

Kayentis

186 South Street Suite 600

Boston, MA 02111

UNITED STATES

Contact: Guillaume Juge, CEO

BROCHURES